High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints

Area of Science:

• Gynecologic Oncology
• Cancer Biology
• Pathology

Background:

• Ovarian cancer is the most fatal gynecologic malignancy, with mortality rates unchanged since 1980.
• Unlike other cancers, ovarian cancer comprises multiple distinct subtypes, with high-grade serous ovarian cancer (HGSOC) being the most prevalent and lethal.
• Despite grim statistics, advancements in understanding HGSOC's fundamental biology are paving the way for improved clinical outcomes.

Purpose of the Study:

• To provide a comprehensive overview of ovarian cancer's clinical-pathological features.
• To specifically detail the high-grade serous ovarian cancer (HGSOC) subtype.
• To update on recent scientific literature concerning HGSOC's origin, etiology, and molecular-genetic basis.

Main Methods:

• Literature review of clinical-pathological features.
• Analysis of recent scientific updates on HGSOC.
• Focus on molecular-genetic basis and etiology.

Main Results:

• Ovarian cancer is not a single disease but a spectrum of malignancies.
• High-grade serous ovarian cancer (HGSOC) is the predominant and most fatal subtype.
• Progress is being made in understanding HGSOC's biology and influencing treatment.

Conclusions:

• A deeper understanding of HGSOC's biology is crucial for improving patient outcomes.
• Novel treatment strategies are emerging based on recent scientific discoveries.
• Continued research into the origin, etiology, and molecular genetics of HGSOC is essential.